Repurposing vaccine-induced anti-HBV antibodies for endogenous immunotherapy against EGFR-positive tumors

This study introduces a novel immunotherapy strategy using engineered bifunctional molecules to redirect vaccine-induced anti-Hepatitis B Virus (HBV) antibodies toward Epidermal Growth Factor Receptor (EGFR)-positive tumors. The conjugates were synthesized...